Atlas Trials

Body Composition Analysis and Time to Emergence From Remimazolam

Clinical trial NCT05512559 · UNKNOWN

Trial details

NCT number
NCT05512559
Sponsor
Samsung Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
RemimazolamBody Composition
Start date
2022-09-05
Primary completion
2022-12-30
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.